Not Yet Recruiting PHASE2/PHASE3 INTERVENTIONAL 3-arm
NCT07448415
Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma
Evaluation of the Efficacy and Safety of Oral Tranexamic Acid Combined With Glutathione-assisted Microneedling Versus Each Therapy Alone in the Treatment of Melasma
Sponsor: Assiut University
Conditions
Melasma
Interventions
Glutathione Oral tranexamic acid microneedling
Updated 1 time since 2026 Last updated: Feb 28, 2026 Started: Feb 28, 2026 Primary completion: Feb 28, 2027 Completion: Apr 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2/PHASE3 trial investigates Melasma and is currently actively recruiting participants. Assiut University leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2/PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Assiut University
Data source: Assiut University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.